FCGSX
Price
$27.55
Change
+$0.16 (+0.58%)
Updated
Sep 9 closing price
Net Assets
19.27B
RGAGX
Price
$87.28
Change
+$0.31 (+0.36%)
Updated
Sep 9 closing price
Net Assets
334.15B
Interact to see
Advertisement

FCGSX vs RGAGX

Header iconFCGSX vs RGAGX Comparison
Open Charts FCGSX vs RGAGXBanner chart's image
Fidelity Series Growth
Price$27.55
Change+$0.16 (+0.58%)
VolumeN/A
Net Assets19.27B
American Funds Growth Fund of Amer R6
Price$87.28
Change+$0.31 (+0.36%)
VolumeN/A
Net Assets334.15B
FCGSX vs RGAGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FCGSX vs. RGAGX commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCGSX is a StrongBuy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 334B vs. FCGSX (19.3B). RGAGX pays higher dividends than FCGSX: RGAGX (0.59) vs FCGSX (0.41). FCGSX was incepted earlier than RGAGX: FCGSX (12 years) vs RGAGX (16 years). RGAGX (0.30) is less costly to investors than FCGSX (0.00). FCGSX is a more actively managed with annual turnover of: 27.00 vs. RGAGX (25.00). FCGSX has a lower initial minimum investment than RGAGX: FCGSX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 22.13 vs. FCGSX (18.61). RGAGX return over 5 years is better than : 46.68 vs. FCGSX (9.45).
FCGSXRGAGXFCGSX / RGAGX
Total Expense Ratio0.000.30-
Annual Report Gross Expense Ratio0.000.30-
Fund Existence12 years16 years-
Gain YTD13.30816.66080%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets19.3B334B6%
Annual Yield % from dividends0.410.5970%
Returns for 1 year18.6122.1384%
Returns for 3 years79.5654.30147%
Returns for 5 years9.4546.6820%
Returns for 10 years124.86103.98120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBX1.120.06
+5.66%
Mobix Labs
VSTA4.560.02
+0.44%
Vasta Platform Limited
TDACU10.40N/A
N/A
Translational Development Acquisition Corp
GRFS10.11-0.02
-0.20%
Grifols SA
BCRX8.19-0.08
-0.97%
BioCryst Pharmaceuticals